Healthcare

Eli Lilly & Company's stock posted significant gains, outperforming the broader pharmaceutical sector, following two major announcements. The company secured...

Investors in the biotech sector are closely monitoring Ocular Therapeutix as it advances through a pivotal stage of its clinical...

For investors in Achieve Life Sciences, all roads lead to a single date: June 20, 2026. This is the deadline...

BioNxt Solutions has unveiled a strategic pivot designed to position the company at the forefront of one of the pharmaceutical...

Roche has secured significant regulatory approvals across two major markets, delivering a strategic boost to its high-margin diagnostics business. The...

For investors in Telix Pharmaceuticals, 2026 is shaping up to be a defining period. The company’s commercial prospects hinge on...

BioNTech's stock has faced significant headwinds from founder transitions and subdued financial forecasts. However, developments within its research pipeline offer...

Eli Lilly and Company is approaching a pivotal period marked by two significant catalysts. While the pharmaceutical giant's stock has...

Danish pharmaceutical giant Novo Nordisk has achieved a landmark regulatory victory with the U.S. Food and Drug Administration (FDA) granting...

The Swiss hearing solutions group Sonova is taking decisive action to refine its business focus. By announcing the sale of...